Azenta Inc. (AZTA)
51.41
-0.86 (-1.65%)
At close: Jan 14, 2025, 3:59 PM
51.44
0.06%
After-hours Jan 14, 2025, 04:00 PM EST
undefined% (undefined)
| Bid | 35.8 |
| Market Cap | 2.35B |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -3.09 |
| PE Ratio (ttm) | -16.64 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 82.3 |
| Volume | 247,146 |
| Avg. Volume (20D) | 773,740 |
| Open | 52.22 |
| Previous Close | 52.27 |
| Day's Range | 50.47 - 53.47 |
| 52-Week Range | 38.82 - 69.16 |
| Beta | undefined |
About AZTA
Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and h...
Industry Medical - Instruments & Supplies
Sector Healthcare
IPO Date Feb 2, 1995
Employees 3,300
Stock Exchange NASDAQ
Ticker Symbol AZTA
Website https://www.azenta.com
Analyst Forecast
According to 5 analyst ratings, the average rating for AZTA stock is "Buy." The 12-month stock price forecast is $57.5, which is an increase of 11.85% from the latest price.
Buy 60.00%
Hold 40.00%
Sell 0.00%
Next Earnings Release
Azenta Inc. is scheduled to release its earnings on Feb 5, 2025,
during market hours.
Analysts project revenue of $149.55M, reflecting a -3.09% YoY shrinking and earnings per share of 0.06, making a 200.00% increase YoY.
Analysts project revenue of $149.55M, reflecting a -3.09% YoY shrinking and earnings per share of 0.06, making a 200.00% increase YoY.
3 weeks ago ·
Source
+7.21%
Azenta shares are trading higher after Stephens & ...
Unlock content with
Pro Subscription
1 month ago ·
Source
+9.14%
Azenta shares are trading higher after the company announced it will join the S&P SmallCap 600.
